These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26849450)

  • 1. Beat Rate Variability in Murine Embryonic Stem Cell-Derived Cardiomyocytes: Effect of Antiarrhythmic Drugs.
    Niehoff J; Matzkies M; Nguemo F; Hescheler J; Reppel M
    Cell Physiol Biochem; 2016; 38(2):646-58. PubMed ID: 26849450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Antiarrhythmic Drugs on the Beat Rate Variability of Human Embryonic and Human Induced Pluripotent Stem Cell Derived Cardiomyocytes.
    Niehoff J; Matzkies M; Nguemo F; Hescheler J; Reppel M
    Sci Rep; 2019 Oct; 9(1):14106. PubMed ID: 31575920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of melatonin on the heart rhythm - An in vitro simulation with murine embryonic stem cell derived cardiomyocytes.
    Niehoff J; Matzkies M; Nguemo F; Hescheler J; Reppel M
    Biomed Pharmacother; 2021 Apr; 136():111245. PubMed ID: 33450496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening.
    Liang H; Matzkies M; Schunkert H; Tang M; Bonnemeier H; Hescheler J; Reppel M
    Cell Physiol Biochem; 2010; 25(4-5):459-66. PubMed ID: 20332627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of light on the beat rate variability of murine embryonic stem cell derived cardiomyocytes.
    Niehoff J; Matzkies M; Nguemo F; Hescheler J; Reppel M
    Biomed Pharmacother; 2022 Feb; 146():112589. PubMed ID: 34968926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From beat rate variability in induced pluripotent stem cell-derived pacemaker cells to heart rate variability in human subjects.
    Ben-Ari M; Schick R; Barad L; Novak A; Ben-Ari E; Lorber A; Itskovitz-Eldor J; Rosen MR; Weissman A; Binah O
    Heart Rhythm; 2014 Oct; 11(10):1808-1818. PubMed ID: 25052725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes.
    Caspi O; Itzhaki I; Kehat I; Gepstein A; Arbel G; Huber I; Satin J; Gepstein L
    Stem Cells Dev; 2009; 18(1):161-72. PubMed ID: 18510453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.
    Shi M; Tien NT; de Haan L; Louisse J; Rietjens IMCM; Bouwmeester H
    Toxicol In Vitro; 2020 Sep; 67():104891. PubMed ID: 32446838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays.
    Gilchrist KH; Lewis GF; Gay EA; Sellgren KL; Grego S
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):249-57. PubMed ID: 26232523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical microscopy imaging for the diagnosis of the pharmacological reaction of mouse embryonic stem cell-derived cardiomyocytes (mESC-CMs).
    Ikeuchi T; Espulgar W; Shimizu E; Saito M; Lee JK; Dou X; Yamaguchi Y; Tamiya E
    Analyst; 2015 Oct; 140(19):6500-7. PubMed ID: 26309911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes.
    Reppel M; Igelmund P; Egert U; Juchelka F; Hescheler J; Drobinskaya I
    Cell Physiol Biochem; 2007; 19(5-6):213-24. PubMed ID: 17495462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action potential-based MEA platform for in vitro screening of drug-induced cardiotoxicity using human iPSCs and rat neonatal myocytes.
    Jans D; Callewaert G; Krylychkina O; Hoffman L; Gullo F; Prodanov D; Braeken D
    J Pharmacol Toxicol Methods; 2017 Sep; 87():48-52. PubMed ID: 28549786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes.
    Tertoolen LGJ; Braam SR; van Meer BJ; Passier R; Mummery CL
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1135-1141. PubMed ID: 28153730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro chronotropic effects of Erythrina senegalensis DC (Fabaceae) aqueous extract on mouse heart slice and pluripotent stem cell-derived cardiomyocytes.
    Nembo EN; Atsamo AD; Nguelefack TB; Kamanyi A; Hescheler J; Nguemo F
    J Ethnopharmacol; 2015 May; 165():163-72. PubMed ID: 25680843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation.
    Shinozawa T; Furukawa H; Sato E; Takami K
    J Biomol Screen; 2012 Jun; 17(5):683-91. PubMed ID: 22274911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J; Kamalakar A; Yang X; Word B; Stockbridge N; Lyn-Cook B; Pang L
    Toxicol Sci; 2017 Mar; 156(1):25-38. PubMed ID: 28031415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements.
    Nguemo F; Šarić T; Pfannkuche K; Watzele M; Reppel M; Hescheler J
    Cell Physiol Biochem; 2012; 29(5-6):819-32. PubMed ID: 22613982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.
    Izumi-Nakaseko H; Hagiwara-Nagasawa M; Naito AT; Goto A; Chiba K; Sekino Y; Kanda Y; Sugiyama A
    J Pharmacol Sci; 2018 Aug; 137(4):372-378. PubMed ID: 30126708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
    Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.